News and Press Releases
Press releases
Theralase Achieves Stability Milestone of Lead Anti-Cancer Drug
Press ReleaseToronto, Ontario – April 22, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotech company focused on commercialization of medical devices to eliminate pain and development o...
Theralase Research Published in International Peer-Reviewed Journal
Press ReleaseToronto, Ontario – April 15, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and de...
Theralase Provides Update on 2016 Strategic Initiatives
Press ReleaseToronto, Ontario – March 18, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and de...
Theralase Debuts Next Generation Therapeutic Laser in US
Press ReleaseToronto, Ontario – January 14, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
Theralase to Present at Noble Investor Conference
Press ReleaseToronto, Ontario – January 13, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
Theralase to Present at AlphaNorth Capital Conference
Press ReleaseToronto, Ontario – January 12, 2016, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and ...
University Health Network Review Ethics Board Approves Clinical Study for Anti-Cancer Drug
Press ReleaseToronto, Ontario – December 29, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and...
Theralase Launches Next Generation Therapeutic Laser in Canada
Press ReleaseToronto, Ontario – December 15, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and...
Theralase Releases 3Q2015 Financials
Press ReleaseToronto, Ontario – November 27, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and...
Theralase Launches Next Generation Therapeutic Laser in USA
Press ReleaseToronto, Ontario – November 26, 2015, Theralase Technologies Inc. (“Theralase” or the “Company”) (TLT:TSXV) (TLTFF:OTC), a leading biotechnology manufacturer focused on commercializing medical technologies to eliminate pain and...
in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.